<DOC>
	<DOCNO>NCT00199355</DOCNO>
	<brief_summary>To establish efficacy 20 mg/day 40 mg/day dos istradefylline reduce percentage OFF time patient advance Parkinson 's disease ( PD ) treat levodopa .</brief_summary>
	<brief_title>A Study Istradefylline ( KW-6002 ) Treatment Parkinson 's Disease Patients Taking Levodopa</brief_title>
	<detailed_description>To establish efficacy 20 mg/d 40mg/d dos istradefylline reduce percentage OFF time patient advance Parkinson 's disease ( PD ) treat levodopa . Patients meet entry criterion randomize 1:1:1 ratio double blind treatment oral dose 20 40mg/d istradefylline match placebo . Patients treat 12 week interim visit end treatment visit ass efficacy safety istradefylline .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Istradefylline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>1 . UK Parkinson 's Disease Society ( UKPDS ) brain bank criterion ( Step 1 2 ) PD . 2 . PD stag 24 OFF state Modified Hoehn Yahr Scale . 3 . On levodopa/DCI least one year , stable dose past 4 week . 4 . Currently take least three dos levodopa/DCI per day . 5 . Predictable end dose wear . 6 . Able satisfactorily complete Hauser version Parkinson 's diary . 7 . Have average 120 minute OFF time two 24 hour diary . 8 . On stable regimen medication administer within normal therapeutic limit Parkinson 's disease least four week randomization . 9 . Be least 30 year age . 1 . Neurosurgical treatment PD . 2 . History psychosis . 3 . Diagnosis atypical Parkinsonism secondary Parkinsonism variant . 4 . Diagnosis cancer within 5 year . 5 . Diagnosis clinically significant illness organ system . 6 . Minimental status examination score 25 less . 7 . Taking excluded medication . 8 . History drug alcohol abuse dependence within past two year . 9 . History seizures neurological malignant syndrome . 10 . Clinical depression . 11 . Pregnant lactating female .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>levodopa</keyword>
	<keyword>end dose wear</keyword>
	<keyword>OFF time</keyword>
</DOC>